A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder

The Journal of Clinical Psychiatry ◽

10.4088/jcp.v68n0207 ◽

2007 ◽

Vol 68 (02) ◽

pp. 224-236 ◽

Author(s):

Michael E. Thase ◽

Sara A. Corya ◽

Olawale Osuntokun ◽

Michael Case ◽

David B. Henley ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Treatment Resistant ◽

Major Depressive ◽

Double Blind ◽

Blind Comparison

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled Trial of Pramipexole Augmentation in Treatment-Resistant Major Depressive Disorder

The Journal of Clinical Psychiatry ◽

10.4088/jcp.12m08093 ◽

2013 ◽

Vol 74 (07) ◽

pp. e636-e641 ◽

Author(s):

Cristina Cusin ◽

Nadia Iovieno ◽

Dan V. Iosifescu ◽

Andrew A. Nierenberg ◽

Maurizio Fava ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Controlled Trial ◽

Treatment Resistant ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder

Neuropsychopharmacology ◽

10.1038/npp.2017.106 ◽

2017 ◽

Vol 42 (13) ◽

pp. 2567-2574 ◽

Author(s):

Sanjay J Mathew ◽

Ralitza Gueorguieva ◽

Cynthia Brandt ◽

Maurizio Fava ◽

Gerard Sanacora

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Treatment Resistant ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A double-blind comparison of moclobemide and toloxatone in out-patients presenting a major depressive disorder

Psychopharmacology ◽

10.1007/bf02246253 ◽

1992 ◽

Vol 106 (S1) ◽

pp. S118-S119 ◽

Author(s):

P. Lemoine ◽

C. Mirabaud

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Major Depressive ◽

Double Blind ◽

Blind Comparison

Download Full-text

P.1.207 Double-blind comparison of escitalopram and venlafaxine XR in the treatment of major depressive disorder

European Neuropsychopharmacology ◽

10.1016/s0924-977x(03)91917-1 ◽

2003 ◽

Vol 13 ◽

pp. S263 ◽

Author(s):

R. Bielski ◽

D. Ventura ◽

C. Chang ◽

A. Korotzer

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Major Depressive ◽

Double Blind ◽

Blind Comparison

Download Full-text

Relapse Prevention in Major Depressive Disorder After Successful Acute Electroconvulsive Treatment: a 6-month Double-blind Comparison of Three Fixed Dosages of Escitalopram and a Fixed Dose of Nortriptyline – Lessons from a Failed Randomised Trial of the Danish University Antidepressant Group (DUAG-7)

Pharmacopsychiatry ◽

10.1055/s-0035-1565063 ◽

2015 ◽

Vol 48 (07) ◽

pp. 274-278 ◽

Author(s):

K. Martiny ◽

E. Larsen ◽

R. Licht ◽

C. Nielsen ◽

P. Damkier ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Relapse Prevention ◽

Randomised Trial ◽

Major Depressive ◽

Double Blind ◽

Electroconvulsive Treatment ◽

Blind Comparison

Download Full-text

Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder: A Randomized, Double-Blind Comparison With Sertraline

Yearbook of Psychiatry and Applied Mental Health ◽

10.1016/j.ypsy.2010.10.061 ◽

2011 ◽

Vol 2011 ◽

pp. 250-251

Author(s):

J.C. Ballenger

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Activity Cycle ◽

Anxiety Symptoms ◽

The Novel ◽

Major Depressive ◽

Double Blind ◽

Blind Comparison ◽

Download Full-text

Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder

International Clinical Psychopharmacology ◽

10.1097/00004850-199903000-00003 ◽

1999 ◽

Vol 14 (2) ◽

pp. 73-80 ◽

Author(s):

J Massana ◽

H-J M??llerb ◽

G D Burrows ◽

R M Montenegro

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Major Depressive ◽

Double Blind ◽

Blind Comparison

Download Full-text

Randomized, double‐blind comparison of aripiprazole/sertraline combination and placebo/sertraline combination in patients with major depressive disorder

Psychiatry and Clinical Neurosciences ◽

10.1111/pcn.12663 ◽

2018 ◽

Vol 72 (8) ◽

pp. 591-601 ◽

Author(s):

Kunitoshi Kamijima ◽

Mahito Kimura ◽

Kazuo Kuwahara ◽

Yuri Kitayama ◽

Yoshihiro Tadori

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Major Depressive ◽

Double Blind ◽

Blind Comparison

Download Full-text

P.8.a.053 A double-blind placebo-controlled study of adjunctive risperidone for treatment-resistant major depressive disorder

European Neuropsychopharmacology ◽

10.1016/s0924-977x(06)70794-5 ◽

2006 ◽

Vol 16 ◽

pp. S562 ◽

Author(s):

G.M. Gharabawi ◽

C.M. Canuso ◽

G.J. Pandina ◽

C.A. Bossie ◽

M. Kujawa ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Controlled Study ◽

Treatment Resistant ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Improvement in Subjective Sleep in Major Depressive Disorder With a Novel Antidepressant, Agomelatine: Randomized, Double-Blind Comparison With Venlafaxine

Yearbook of Psychiatry and Applied Mental Health ◽

10.1016/s0084-3970(08)79307-1 ◽

2009 ◽

Vol 2009 ◽

pp. 213-214

Author(s):

J.C. Ballenger

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Major Depressive ◽

Double Blind ◽

Subjective Sleep ◽

Blind Comparison

Download Full-text